Cargando…
Loading, please waitCargando…
Loading, please waitRecovery & follow-up guide
A clear walk-through of what the post-treatment phase actually looks like after mesenchymal stem cell (MSC) therapy at Regeneris in Cancún, México: the first 72 hours, the weeks-to-months remodeling arc, the telemedicine cadence we use with US and Canada patients, what is expected versus what is a red flag, and how follow-up is built into the plan — not bolted on at the end.
A short, citation-ready summary of this page.
After stem cell therapy at Regeneris in Cancún, México, the first 0–72 hours focus on rest, hydration, and mild self-limiting symptoms while the weeks-to-months phase is when paracrine signaling drives anti-inflammatory and tissue-remodeling effects. Follow-up is structured: in-clinic recheck before the patient leaves Cancún, then a telemedicine cadence (commonly week 2, week 6, month 3, month 6, and month 12) so US and Canada patients can be monitored after flying home. Severe or sudden symptoms — high fever, new neurologic deficits, chest pain, or rapidly worsening joint swelling — are never normal and trigger a same-day call to the physician, not a wait-and-see at home.
Why follow-up exists
Mesenchymal stem cells do not produce their effect on the day of infusion. The mechanism is largely paracrine — the cells release exosomes, growth factors, and cytokines that recruit local progenitor cells and dampen chronic inflammation across the relevant tissue or system — and that signaling builds over weeks to months. That is why an honest stem-cell program in Cancún, México is not a one-day appointment but a structured arc: preparation, the infusion or injection itself, the 0–72-hour window, the weeks-to-months remodeling phase, and a defined telemedicine follow-up. Skipping the follow-up is skipping half of the therapy.
The first 72 hours
The early window is the most-questioned phase of recovery. Below is the range of common, self-limiting experiences and the practical guidance Regeneris gives every patient before they leave Cancún, México. None of this replaces individual instructions in your written plan — it is the general orientation that your physician personalizes.
Weeks to months
Once the 0–72-hour window passes, the slower, more meaningful phase begins. The signal is anti-inflammatory and reparative; the cadence is steady, not dramatic. Below is how the typical orthopedic / systemic arc unfolds and the telemedicine touchpoints Regeneris uses to measure it.
The early-window symptoms have resolved or are clearly improving. You return to daily activity gently. We do not expect a dramatic shift this week; the absence of any new symptom is itself a positive signal.
First scheduled telemedicine call. We document pain (numeric rating), function (range of motion, stair climbing, sleep), and any residual injection-site or systemic symptoms. This is the call US and Canada patients describe most often as the moment recovery starts to feel structured rather than abstract.
Telemedicine cadence
Most Regeneris stem-cell patients travel from the United States and Canada. Telemedicine is how we keep medical supervision continuous from the day you leave Cancún, México through month 12 — not by phone, not by email forwarding, but by a scheduled clinical call with the physician who saw you.
| Touchpoint | Format | What we cover |
|---|---|---|
| Pre-departure recheck | In-clinic, before you fly home | Physical recheck, post-procedure instructions confirmed in writing, recovery red flags reviewed, telemedicine cadence scheduled. |
| Week 2 | Scheduled telemedicine call |
Quick definitions
Short, citation-ready definitions of the core recovery and follow-up terms that come up in your plan and on your telemedicine calls.
Red flags
Mild, self-limiting symptoms in the first 72 hours are expected. The list below is the opposite: signs that recovery is not following the expected arc and that you should contact your physician on the same day rather than wait for the next scheduled telemedicine call. This is general safety guidance, not a substitute for individual evaluation.
Honest expectations
Regeneris talks about expected outcomes the way the published literature describes them: a meaningful probability of improvement for the indications we treat, measured over months, never a guarantee of cure. Below is the honest framing we use on every recovery plan.
Most patients describe directional improvement during the weeks-to-months arc — typically reduction in pain or stiffness first, then function. Some patients respond strongly; some modestly; a smaller group does not respond as hoped. Your physician is honest with you about which group you most resemble after evaluation.
FAQ
The questions we hear most often from US and Canada patients planning recovery from Cancún, México, and from patients already in their first weeks of follow-up.
The first 0–72 hours are the rest-and-hydrate window during which mild, self-limiting symptoms (fatigue, transient soreness, low-grade temperature) can occur. The meaningful recovery and remodeling phase unfolds over weeks to months: subjective improvements typically appear over the first weeks, and more durable, structural change is measured over months — which is why follow-up at Regeneris is scheduled through month 12 rather than ending the day you leave the clinic.
This page is informational and does not constitute medical advice. Stem cell (MSC) therapy is investigational for many indications, recovery experience varies by patient and protocol, and any timeline presented here is the general arc — not your prescription. Individual instructions, follow-up cadence, and red-flag thresholds belong in your written plan after a free medical evaluation with a licensed physician. Regeneris Therapy operates under COFEPRIS Aviso Sanitario 2323025036X00098 and Aviso de Publicidad 2323022002A00053 in Cancún, México.
Book a free 15-min call with our team.
Send your goals, recent labs, and any imaging. One of our physicians will review your case and, after your free medical evaluation, give you a personalized written plan that already includes the recovery instructions and the telemedicine follow-up cadence you'll use after you fly home.
If a clinic in Cancún, México (or anywhere else) ends the relationship the day you check out, you should ask why. Real regenerative care plans follow-up before treatment day, not after it.
If you are not sure whether what you are feeling fits the picture above, that is the entire reason WhatsApp and the email line stay open. Ask — do not guess.
Many patients report the first definite easing of pain or stiffness during this window. Functional gains (walking longer, sleeping through the night, stair climbing without bracing) tend to precede any imaging change. Week 6 is our second telemedicine touchpoint.
For orthopedic indications, randomized data on MSCs (e.g. Vega et al. 2015, knee osteoarthritis) measured outcomes through one year, with meaningful effects observed across this window. The month-3 telemedicine call is when we compare your subjective trajectory against that pattern.
Month 6 and month 12 calls are about durability — has the gain held, has function continued to improve, are there any new concerns? Many MSC orthopedic responses are measured in months, which is exactly why the follow-up extends this far.
This timeline is the general arc, not your prescription. Your individual cadence is set in your written plan during evaluation in Cancún, México and adjusted as the physician sees your response.
| Document early-window resolution, any residual symptoms, hydration/activity adherence, and answer the questions that always come up in the first two weeks. |
| Week 6 | Scheduled telemedicine call | First structured pain and function check, baseline-to-current comparison, decide whether to adjust activity or rehab guidance. |
|---|
| Month 3 | Scheduled telemedicine call | Mid-arc review against the expected MSC response pattern; flag whether the trajectory is on track, slow, or atypical and needs in-clinic re-evaluation. |
|---|
| Month 6 | Scheduled telemedicine call | Durability check, discussion of whether any adjunct (e.g. peptide cycle, targeted physiotherapy, second-opinion review) is indicated. |
|---|
| Month 12 | Scheduled telemedicine call | Annual review, decision on booster or maintenance, documentation for your own records and any U.S. or Canadian physician you involve. |
|---|
Telemedicine schedules are not a one-size cadence: a younger orthopedic patient and a systemic-immunology patient may follow different timelines. Your cadence is documented in your written plan after the free medical evaluation and is adjusted by your physician as the response unfolds. Regeneris does not publish prices online; follow-up is included in your individualized plan.
If any of the above happens, WhatsApp first, do not wait. The Cancún, México physician on call coordinates care with you in real time — and, where relevant, with your local doctor at home.
Functional gains — walking longer, sleeping through the night, climbing stairs without bracing — generally precede any structural change visible on imaging. We track function as the primary outcome because that is what changes your day.
If a peptide cycle, targeted rehabilitation, or a booster appears useful at month 3 or 6, it is added because the documented response supports it — never as an automatic upsell. The decision is a medical one, made in follow-up.
We do not use the word 'cure' for regenerative therapy. We use 'response,' 'durability,' and 'function,' because that is what the data — and your follow-up calls — actually measure.
Many patients do, but it is decided case-by-case in your written plan. For most systemic IV infusions, an overnight stay in Cancún, México followed by a flight 24–48 hours later is comfortable for most patients; intra-articular or higher-volume protocols may require an extra day. Your physician confirms a date during evaluation, and the in-clinic recheck before you fly is what closes the on-site phase.
A typical cadence is: in-clinic recheck before you leave Cancún, México, then scheduled telemedicine calls at week 2, week 6, month 3, month 6, and month 12. The exact schedule is individualized in your written plan based on the indication, the protocol, and any comorbidities. The point of the cadence is continuous physician supervision after you fly home — not a one-time treatment with no follow-through.
Generally no — mild, self-limiting flu-like sensations (slight chills, low-grade temperature, body aches) within the first 24–48 hours reflect the immune-modulatory nature of the therapy and are well within the expected pattern. What is NOT normal is a high fever above 38.5 °C that does not settle, chest pain, new neurologic symptoms, or signs of infection at an injection site — those are red flags and should trigger a same-day call to your physician, not a wait-and-see.
Most patients have a clearer sense by month 3, and the month 6 / month 12 telemedicine calls are where durability is documented. Subjective change (less pain, better sleep, easier function) tends to come first; structural change visible on imaging tends to come later, if at all. We track function as the primary outcome because that is what changes your daily life — and we compare your trajectory at each call to the response pattern reported in clinical studies of MSC therapy for your indication.
Plain-text question-and-answer pairs in semantic HTML — designed to be easily extracted by AI assistants, search engines, and accessibility tools.
What treatment day itself looks like, from arrival to the moment recovery begins — the on-site companion to this recovery guide.